The American Heart Association and the American the College of Cardiology in 2025 issued guidelines to help reduce ...

Medications best known for treating diabetes and supporting weight loss, such as Ozempic and Wegovy, may also change how the body experiences alcohol.

Alcohol’s cancer risk is shaped by a powerful mix of biology, behavior, and social factors—often in ways people don’t expect.

Most people know that smoking causes cancer and that there's no "safe" number of cigarettes that are OK to smoke.

Data were included for 262 adults with a body mass index greater than or equal to 27kg/m2 who were initiated on liraglutide or semaglutide. HealthDay News — Glucagon-like peptide-1 receptor agonists ...

U.S. Surgeon General Dr. Vivek Murthy warned in a recent advisory about alcohol use increasing cancer risk. The advisory notes that alcohol can increase the risk of throat, liver, esophageal, mouth, ...

In the early days of the semaglutide weight loss wave, many of its users reported less interest in alcohol. A study now says that these effects extend well beyond the anecdotal, with individuals in an ...

Weight-loss medications known as glucagon-like peptide-1 (GLP-1) agonists, which have gained popularity for treating type 2 diabetes and obesity, have been shown to have the surprising secondary ...

Investigators sought to determine whether alcohol intake, particularly at higher frequency or greater quantity, was consistently associated with elevated risk for cancer.

A new study from the Texas A&M University School of Public Health explores a theoretical framework for implementing an alcohol reduction strategy to support U.S. college students at high risk for ...

Reductions in alcohol intake noted in high and low consumers; no significant difference seen in percentage reductions for men and women. (HealthDay News) — Glucagon-like peptide-1 receptor agonists ...